The incidental finding of hepatic steatosis on imaging may present an avenue for opportunistic screening, leading to more efficient identification of metabolic dysfunction-associated steatotic liver disease (MASLD) and risk prediction for fibrosis. How can radiologists best facilitate this?

In this episode, Maddi and Jeff sit down with Emily Schonfeld, MD and Andrea Siobhan Kierans, MD to discuss their recent review article about recommendations for when hepatic steatosis is found on imaging and subsequent noninvasive tests to help predict overall fibrosis staging.

Find the JACR article here: https://pubmed.ncbi.nlm.nih.gov/40044315/